交易 Helius Medical Technologies, Inc. - HSDT CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
价差 | 0.0216 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.025457% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.003235% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Helius Medical Technologies Inc ESG Risk Ratings
‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平仓 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
May 26, 2023 | 0.1495 | 0.0046 | 3.17% | 0.1449 | 0.1586 | 0.1449 |
May 25, 2023 | 0.1548 | 0.0039 | 2.58% | 0.1509 | 0.1628 | 0.1509 |
May 24, 2023 | 0.1491 | 0.0040 | 2.76% | 0.1451 | 0.1520 | 0.1451 |
May 23, 2023 | 0.1542 | -0.0055 | -3.44% | 0.1597 | 0.1601 | 0.1408 |
May 22, 2023 | 0.1592 | 0.0045 | 2.91% | 0.1547 | 0.1599 | 0.1547 |
May 19, 2023 | 0.1559 | 0.0012 | 0.78% | 0.1547 | 0.1575 | 0.1499 |
May 18, 2023 | 0.1530 | 0.0010 | 0.66% | 0.1520 | 0.1692 | 0.1477 |
May 17, 2023 | 0.1554 | 0.0088 | 6.00% | 0.1466 | 0.1564 | 0.1465 |
May 16, 2023 | 0.1466 | 0.0005 | 0.34% | 0.1461 | 0.1549 | 0.1451 |
May 15, 2023 | 0.1452 | -0.0029 | -1.96% | 0.1481 | 0.1586 | 0.1361 |
May 12, 2023 | 0.1461 | -0.0144 | -8.97% | 0.1605 | 0.1645 | 0.1373 |
May 11, 2023 | 0.1670 | -0.0008 | -0.48% | 0.1678 | 0.1791 | 0.1643 |
May 10, 2023 | 0.1665 | -0.0046 | -2.69% | 0.1711 | 0.1728 | 0.1615 |
May 9, 2023 | 0.1558 | -0.0029 | -1.83% | 0.1587 | 0.1648 | 0.1547 |
May 8, 2023 | 0.1558 | 0.0058 | 3.87% | 0.1500 | 0.1647 | 0.1479 |
May 5, 2023 | 0.1490 | 0.0022 | 1.50% | 0.1468 | 0.1542 | 0.1452 |
May 4, 2023 | 0.1400 | -0.0050 | -3.45% | 0.1450 | 0.1510 | 0.1358 |
May 3, 2023 | 0.1457 | -0.0187 | -11.37% | 0.1644 | 0.1644 | 0.1237 |
May 2, 2023 | 0.1698 | 0.0055 | 3.35% | 0.1643 | 0.1742 | 0.1643 |
May 1, 2023 | 0.1771 | 0.0015 | 0.85% | 0.1756 | 0.1838 | 0.1681 |
Helius Medical Technologies, Inc. Events
时间(协调世界时) (UTC) | 国家/地区 | 事件 |
---|---|---|
Wednesday, June 7, 2023 | ||
时间(协调世界时) (UTC) 23:00 | 国家/地区 US
| 事件 Helius Medical Technologies Inc at LD Micro Invitational Conference Helius Medical Technologies Inc at LD Micro Invitational ConferenceForecast -Previous - |
Monday, August 14, 2023 | ||
时间(协调世界时) (UTC) 10:59 | 国家/地区 US
| 事件 Q2 2023 Helius Medical Technologies Inc Earnings Release Q2 2023 Helius Medical Technologies Inc Earnings ReleaseForecast -Previous - |
Monday, November 13, 2023 | ||
时间(协调世界时) (UTC) 13:30 | 国家/地区 US
| 事件 Q3 2023 Helius Medical Technologies Inc Earnings Release Q3 2023 Helius Medical Technologies Inc Earnings ReleaseForecast -Previous - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
总收入 | 0.787 | 0.522 | 0.661 | 1.496 | 0.478 |
总营业费用 | 16.303 | 18.664 | 15.047 | 25.492 | 27.153 |
销售/一般/行政费用,总计 | 10.64 | 12.158 | 9.404 | 16.521 | 17.214 |
研究与开发 | 4.262 | 5.99 | 4.582 | 8.061 | 9.939 |
营业收入 | -15.516 | -18.142 | -14.386 | -23.996 | -26.675 |
利息收入(费用),非经营净值 | 1.437 | 0.01 | 0.193 | 14.12 | -2.011 |
其他,净值 | 0.007 | 0 | 0.063 | 0.095 | 0.063 |
税前净收入 | -14.072 | -18.132 | -14.13 | -9.781 | -28.623 |
税后净收入 | -14.072 | -18.132 | -14.13 | -9.781 | -28.623 |
未计算非常项目前的净收益 | -14.072 | -18.132 | -14.13 | -9.781 | -28.623 |
净收入 | -14.072 | -18.132 | -14.13 | -9.781 | -28.623 |
普通股股东可获收益 (不含非经常性项目) | -14.072 | -18.132 | -14.13 | -9.781 | -28.623 |
普通股股东可获收益 (含非經常性項目) | -14.072 | -18.132 | -14.13 | -9.781 | -28.623 |
摊薄净收入 | -14.072 | -18.132 | -14.13 | -9.781 | -28.623 |
摊薄后加权平均股 | 13.4972 | 2.45678 | 1.19777 | 0.75289 | 0.651 |
扣除特别项目的每股摊薄盈利 | -1.04259 | -7.38039 | -11.7969 | -12.9912 | -43.9676 |
Dividends per Share - Common Stock Primary Issue | |||||
每股正常摊薄盈利 | -0.9865 | -7.37306 | -11.5381 | -12.9912 | -43.9676 |
非常规项目总计 | |||||
收入 | 0.787 | 0.522 | 0.661 | 1.496 | 0.478 |
收入成本,共计 | 0.463 | 0.298 | 0.388 | 0.846 | 0 |
毛利 | 0.324 | 0.224 | 0.273 | 0.65 | 0.478 |
Depreciation / Amortization | 0.181 | 0.2 | 0.363 | 0.064 | 0 |
摊薄调整 | 0 | ||||
异常费用(收入) | 0.757 | 0.018 | 0.31 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
总收入 | 0.282 | 0.196 | 0.119 | 0.19 | 0.258 |
收入 | 0.282 | 0.196 | 0.119 | 0.19 | 0.258 |
收入成本,共计 | 0.15 | 0.101 | 0.088 | 0.124 | 0.129 |
毛利 | 0.132 | 0.095 | 0.031 | 0.066 | 0.129 |
总营业费用 | 2.951 | 5.049 | 3.549 | 4.754 | 4.36 |
销售/一般/行政费用,总计 | 1.967 | 3.393 | 2.461 | 2.819 | 2.376 |
研究与开发 | 0.794 | 0.751 | 0.953 | 1.764 | 1.808 |
Depreciation / Amortization | 0.04 | 0.047 | 0.047 | 0.047 | 0.047 |
营业收入 | -2.669 | -4.853 | -3.43 | -4.564 | -4.102 |
利息收入(费用),非经营净值 | -2.223 | 3.823 | -0.38 | 0.217 | 0 |
其他,净值 | 0.006 | 0 | 0 | 0.001 | 0 |
税前净收入 | -4.886 | -1.03 | -3.81 | -4.346 | -4.102 |
税后净收入 | -4.886 | -1.03 | -3.81 | -4.346 | -4.102 |
未计算非常项目前的净收益 | -4.886 | -1.03 | -3.81 | -4.346 | -4.102 |
净收入 | -4.886 | -1.03 | -3.81 | -4.346 | -4.102 |
普通股股东可获收益 (不含非经常性项目) | -4.886 | -1.03 | -3.81 | -4.346 | -4.102 |
普通股股东可获收益 (含非經常性項目) | -4.886 | -1.03 | -3.81 | -4.346 | -4.102 |
摊薄净收入 | -4.886 | -1.03 | -3.81 | -4.346 | -4.102 |
摊薄后加权平均股 | 28.1972 | 8.5433 | 3.9287 | 3.78787 | 3.13886 |
扣除特别项目的每股摊薄盈利 | -0.17328 | -0.12056 | -0.96979 | -1.14735 | -1.30684 |
每股正常摊薄盈利 | -0.17328 | -0.03195 | -0.96979 | -1.14735 | -1.30684 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
异常费用(收入) | 0 | 0.757 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流动资产总额 | 16.697 | 12.594 | 4.685 | 7.241 | 26.961 |
现金和短期投资 | 14.549 | 11.005 | 3.331 | 5.459 | 25.583 |
Cash | 14.549 | 11.005 | 3.331 | 5.459 | 25.583 |
应收账款总额,净额 | 0.343 | 0.251 | 0.23 | 0.574 | 0.275 |
Accounts Receivable - Trade, Net | 0.071 | 0.066 | 0.074 | 0.21 | 0.275 |
Prepaid Expenses | 1.216 | 0.862 | 0.735 | 0.61 | 0.447 |
Total Assets | 17.287 | 14.102 | 6.547 | 10.347 | 27.827 |
Total Current Liabilities | 1.988 | 2.653 | 2.424 | 3.802 | 17.973 |
Payable/Accrued | |||||
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | |
Other Current Liabilities, Total | 0.027 | 0.148 | 0.281 | 0.435 | 13.769 |
Total Liabilities | 9.136 | 2.846 | 2.676 | 4.512 | 17.973 |
Total Long Term Debt | 0 | 0 | 0 | 0 | |
Total Equity | 8.151 | 11.256 | 3.871 | 5.835 | 9.854 |
Common Stock | 0.028 | 0.004 | 0.001 | 0.031 | 0.026 |
Additional Paid-In Capital | 159.618 | 149.412 | 123.872 | 111.479 | 105.411 |
Retained Earnings (Accumulated Deficit) | -151.107 | -137.035 | -118.903 | -104.773 | -94.992 |
Other Equity, Total | -0.388 | -1.125 | -1.099 | -0.902 | -0.591 |
Total Liabilities & Shareholders’ Equity | 17.287 | 14.102 | 6.547 | 10.347 | 27.827 |
Total Common Shares Outstanding | 28.2073 | 3.78067 | 1.48436 | 0.87763 | 0.7379 |
Property/Plant/Equipment, Total - Net | 0.45 | 0.412 | 0.576 | 1.264 | 0.554 |
Property/Plant/Equipment, Total - Gross | 0.653 | 0.779 | 1.449 | 0.63 | |
Accumulated Depreciation, Total | -0.241 | -0.203 | -0.185 | -0.076 | |
Other Long Term Assets, Total | 0 | 0.018 | 0.018 | ||
Accounts Payable | 0.627 | 1.069 | 0.747 | 1.676 | 2.392 |
Accrued Expenses | 1.334 | 1.436 | 1.396 | 1.691 | 1.812 |
Total Inventory | 0.589 | 0.476 | 0.389 | 0.598 | 0.392 |
Other Current Assets, Total | 0 | 0.264 | |||
Note Receivable - Long Term | 0 | 0.294 | |||
Other Liabilities, Total | 7.148 | 0.193 | 0.252 | 0.71 | 0 |
Goodwill, Net | 0 | 0.763 | 0.759 | 1.242 | |
Intangibles, Net | 0.14 | 0.333 | 0.527 | 0.582 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
流动资产总额 | 16.697 | 18.217 | 5.064 | 8.026 | 12.594 |
现金和短期投资 | 14.549 | 16.658 | 3.273 | 6.31 | 11.005 |
Cash | 14.549 | 16.658 | 3.273 | 6.31 | 11.005 |
应收账款总额,净额 | 0.343 | 0.217 | 0.196 | 0.245 | 0.251 |
Accounts Receivable - Trade, Net | 0.071 | 0.021 | 0.009 | 0.06 | 0.066 |
Total Inventory | 0.589 | 0.609 | 0.577 | 0.52 | 0.476 |
Prepaid Expenses | 1.216 | 0.733 | 0.996 | 0.951 | 0.862 |
Total Assets | 17.287 | 18.859 | 6.546 | 9.618 | 14.102 |
Property/Plant/Equipment, Total - Net | 0.45 | 0.464 | 0.493 | 0.52 | 0.412 |
Goodwill, Net | 0 | 0.753 | 0.777 | 0.763 | |
Intangibles, Net | 0.14 | 0.178 | 0.236 | 0.291 | 0.333 |
Other Long Term Assets, Total | 0.004 | ||||
Total Current Liabilities | 1.988 | 1.2 | 1.777 | 2.199 | 2.653 |
Accounts Payable | 0.627 | 0.57 | 1.043 | 1.111 | 1.069 |
Accrued Expenses | 1.334 | 0.604 | 0.706 | 1.059 | 1.436 |
Other Current Liabilities, Total | 0.027 | 0.026 | 0.028 | 0.029 | 0.148 |
Total Liabilities | 9.136 | 5.898 | 2.044 | 2.488 | 2.846 |
Other Liabilities, Total | 7.148 | 4.698 | 0.267 | 0.289 | 0.193 |
Total Equity | 8.151 | 12.961 | 4.502 | 7.13 | 11.256 |
Preferred Stock - Non Redeemable, Net | |||||
Common Stock | 0.028 | 0.028 | 0.004 | 0.004 | 0.004 |
Additional Paid-In Capital | 159.618 | 159.386 | 150.665 | 149.834 | 149.412 |
Retained Earnings (Accumulated Deficit) | -151.107 | -146.221 | -145.191 | -141.381 | -137.035 |
Other Equity, Total | -0.388 | -0.232 | -0.976 | -1.327 | -1.125 |
Total Liabilities & Shareholders’ Equity | 17.287 | 18.859 | 6.546 | 9.618 | 14.102 |
Total Common Shares Outstanding | 28.2073 | 28.2013 | 4.19511 | 3.7948 | 3.78067 |
Property/Plant/Equipment, Total - Gross | 0.786 | 0.653 | |||
Accumulated Depreciation, Total | -0.266 | -0.241 | |||
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | |
Total Long Term Debt | 0 | 0 | 0 | 0 | |
Other Current Assets, Total | 0.022 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | -18.132 | -14.13 | -9.781 | -28.623 | |
经营活动产生的现金 | -13.388 | -11.738 | -20.999 | -19.621 | |
非现金物品 | 4.305 | 2.926 | -9.132 | 9.961 | |
营运资金的变化 | 0.127 | -1.016 | -2.277 | -1.018 | |
投资活动产生的现金 | -0.056 | -0.009 | -0.769 | -0.44 | |
其他投资现金流量项目,总计 | 0 | 0.061 | -0.416 | ||
融资活动产生的现金 | 21.126 | 9.638 | 1.653 | 40.028 | |
融资现金流项目 | -2.889 | -1.015 | -0.247 | -3.161 | |
股票的发行(报废),净额 | 24.015 | 10.653 | 1.9 | 43.189 | |
外汇效应 | -0.008 | -0.019 | -0.009 | 0.054 | |
现金净变化 | 7.674 | -2.128 | -20.124 | 20.021 | |
经营活动产生的现金 | 0.112 | 0.119 | 0.127 | 0.059 | |
Cash Taxes Paid | 0 | 0 | |||
已付现金利息 | 0 | 0 | |||
资本支出 | -0.056 | -0.07 | -0.353 | -0.44 | |
Amortization | 0.2 | 0.363 | 0.064 | ||
债务的发行(退还),净额 | 0 | 0 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -9.186 | -8.156 | -4.346 | -18.132 | |
Cash From Operating Activities | -12.167 | -8.346 | -4.682 | -13.388 | |
Cash From Operating Activities | 0.074 | 0.05 | 0.025 | 0.112 | |
Amortization | 0.141 | 0.094 | 0.047 | 0.2 | |
Non-Cash Items | -1.768 | 0.765 | 0.195 | 4.305 | |
Changes in Working Capital | -1.428 | -1.099 | -0.603 | 0.127 | |
Cash From Investing Activities | -0.013 | -0.006 | 0.004 | -0.056 | |
Capital Expenditures | -0.019 | -0.012 | -0.002 | -0.056 | |
Cash From Financing Activities | 17.869 | 0.62 | -0.017 | 21.126 | |
Financing Cash Flow Items | -0.775 | -0.024 | -0.017 | -2.889 | |
Issuance (Retirement) of Stock, Net | 18.644 | 0.644 | 0 | 24.015 | |
Foreign Exchange Effects | -0.006 | -0.008 | |||
Net Change in Cash | 5.683 | -7.732 | -4.695 | 7.674 | |
Other Investing Cash Flow Items, Total | 0.006 | 0.006 | 0.006 | 0 | |
Issuance (Retirement) of Debt, Net | 0 | ||||
Cash Interest Paid | 0.927 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
Andreeff Dane C | Individual Investor | 1.9596 | 552898 | 550504 | 2023-04-05 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.9051 | 255381 | 0 | 2023-03-31 | LOW |
Maple Leaf Partners, L.P. | Hedge Fund | 0.5816 | 164095 | 0 | 2023-04-05 | LOW |
Straw Edward M | Individual Investor | 0.3176 | 89607 | 83054 | 2023-05-24 | MED |
Buckman (Paul R) | Individual Investor | 0.3109 | 87711 | 83054 | 2023-05-24 | LOW |
Walter (Blane) | Individual Investor | 0.3104 | 87590 | 83054 | 2023-05-24 | LOW |
Perkins Sherrie Lynn | Individual Investor | 0.3104 | 87590 | 83054 | 2023-05-24 | MED |
Ockner (Matthew D) | Individual Investor | 0.2502 | 70596 | 2310 | 2021-12-31 | |
Delta Investment Management, LLC | Investment Advisor | 0.1995 | 56284 | 0 | 2023-03-31 | MED |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.1738 | 49038 | 28226 | 2023-03-31 | LOW |
UBS Financial Services, Inc. | Investment Advisor | 0.16 | 45157 | 10854 | 2023-03-31 | LOW |
Virtu Americas LLC | Research Firm | 0.1459 | 41166 | 41166 | 2023-03-31 | HIGH |
Millennium Management LLC | Hedge Fund | 0.1407 | 39699 | -22578 | 2023-03-31 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.1253 | 35364 | 0 | 2023-03-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 0.0473 | 13357 | 13357 | 2023-03-31 | HIGH |
Mathiesen (Jeffrey S) | Individual Investor | 0.0423 | 11948 | 0 | 2023-04-05 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.0376 | 10600 | -149000 | 2023-03-31 | HIGH |
Tower Research Capital LLC | Hedge Fund | 0.0326 | 9193 | 2 | 2023-03-31 | HIGH |
Advisor Group, Inc | Investment Advisor | 0.0149 | 4200 | 0 | 2023-03-31 | LOW |
Carson Wealth Management Group | Investment Advisor | 0.0018 | 500 | 0 | 2023-03-31 | LOW |
交易计算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Helius Medical Technologies, Inc. Company profile
关于 Helius Medical Technologies Inc.
Helius医疗技术公司是一家专注于神经系统健康的神经技术公司。 公司专注于开发、许可或收购针对减少神经系统疾病或创伤症状的非侵入性技术。 公司的产品--便携式神经调节刺激器(PoNS)是一种二类非植入性医疗设备,用于短期(14周)治疗多发性硬化症(MS)引起的步态障碍,以及轻度至中度脑外伤(mmTBI)引起的平衡障碍,并与监督下的治疗性运动(PoNS治疗)结合使用。 公司的子公司包括Helius医疗公司、Helius医疗技术(加拿大)公司、Helius NeuroRehab公司、Helius加拿大收购有限公司和Heuro加拿大公司。
Industry: | Advanced Medical Equipment & Technology (NEC) |
642 Newtown Yardley Road
NEWTOWN
PENNSYLVANIA 18940
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球530,000万多名交易者的一份子,选择利用Capital.com进行交易吧。